Literature DB >> 23333296

Formation of alternative proteasomes: same lady, different cap?

Elah Pick1, Tali S Berman.   

Abstract

The 26S proteasome is thought to be a homogenous complex, consisting of a 20S proteolytic core and a 19S regulatory particle that is required for its activation. Two groups have recently reported the activation of archeal 20S by a p97-related double-ring AAA+ ATPase complex, in a similar fashion to that reported for 19S. Since p97 is found in eukaryotes, the existence of a parallel setting in higher organisms is intriguing. Herein, we present supporting data and hypothesize that in eukaryotes, p97 and CSN form a promiscuous, hence hard-to-detect, "alternative cap", enabling the prompt and precise elimination of particular substrates.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333296     DOI: 10.1016/j.febslet.2013.01.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Three old and one new: protein import into red algal-derived plastids surrounded by four membranes.

Authors:  Simone Stork; Julia Lau; Daniel Moog; Uwe-G Maier
Journal:  Protoplasma       Date:  2013-04-24       Impact factor: 3.356

2.  Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution.

Authors:  Diego Sbardella; Grazia Raffaella Tundo; Francesca Sciandra; Manuela Bozzi; Magda Gioia; Chiara Ciaccio; Umberto Tarantino; Andrea Brancaccio; Massimo Coletta; Stefano Marini
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 3.  Functions of the proteasome on chromatin.

Authors:  Tyler S McCann; William P Tansey
Journal:  Biomolecules       Date:  2014-11-21

Review 4.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.